Primary |
Prostate Cancer Metastatic |
27.5% |
Prostate Cancer |
18.9% |
Premedication |
14.3% |
Hormone-refractory Prostate Cancer |
11.7% |
Hypertension |
4.9% |
Product Used For Unknown Indication |
3.8% |
Prophylaxis |
3.4% |
Diabetes Mellitus |
3.0% |
Atrial Fibrillation |
1.5% |
Bone Pain |
1.5% |
Hypercholesterolaemia |
1.5% |
Chemotherapy |
1.1% |
Constipation |
1.1% |
Gastrooesophageal Reflux Disease |
1.1% |
Anxiety |
0.8% |
Blood Glucose |
0.8% |
Blood Pressure |
0.8% |
Metastases To Bone |
0.8% |
Nausea |
0.8% |
Osteopenia |
0.8% |
|
Thrombocytopenia |
16.9% |
Death |
10.2% |
Sepsis |
10.2% |
Septic Shock |
6.8% |
Vomiting |
6.8% |
Haematuria |
5.1% |
Paraesthesia |
5.1% |
Pyrexia |
5.1% |
Syncope |
5.1% |
Enteritis |
3.4% |
Leukocytosis |
3.4% |
Nausea |
3.4% |
Neutropenia |
3.4% |
Paraplegia |
3.4% |
Pulmonary Embolism |
3.4% |
Anaphylactic Shock |
1.7% |
Angiopathy |
1.7% |
Bone Marrow Failure |
1.7% |
Cardiac Failure |
1.7% |
Central Nervous System Lesion |
1.7% |
|
Secondary |
Prostate Cancer Metastatic |
43.8% |
Hormone-refractory Prostate Cancer |
10.8% |
Premedication |
8.8% |
Prostate Cancer |
7.8% |
Prophylaxis |
5.2% |
Hypertension |
4.6% |
Bone Pain |
3.9% |
Diabetes Mellitus |
2.9% |
Anxiety |
2.0% |
Constipation |
1.3% |
Metastases To Bone |
1.3% |
Product Used For Unknown Indication |
1.3% |
Atrial Fibrillation |
1.0% |
Bronchospasm |
1.0% |
Neuralgia |
1.0% |
Pulmonary Embolism |
1.0% |
Vertigo |
1.0% |
Type Ii Diabetes Mellitus |
0.7% |
Coronary Artery Disease |
0.3% |
Hyperlipidaemia |
0.3% |
|
Septic Shock |
16.7% |
Pollakiuria |
12.5% |
Thrombocytopenia |
12.5% |
Death |
8.3% |
Paraplegia |
6.3% |
Sudden Death |
6.3% |
Haematuria |
4.2% |
Overdose |
4.2% |
Prostate Cancer Metastatic |
4.2% |
Syncope |
4.2% |
Enteritis |
2.1% |
Fatigue |
2.1% |
Hypokalaemia |
2.1% |
Hypotonia |
2.1% |
Leukocytosis |
2.1% |
Leukopenia |
2.1% |
Nausea |
2.1% |
Neoplasm Progression |
2.1% |
Neuropathy Peripheral |
2.1% |
Neutropenia |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
31.6% |
Prostate Cancer Metastatic |
23.7% |
Prostate Cancer |
15.8% |
Premedication |
7.9% |
Hypertension |
5.3% |
Prophylaxis |
5.3% |
Blood Cholesterol Increased |
2.6% |
Bone Cancer |
2.6% |
Metastases To Bone |
2.6% |
Pain |
2.6% |
|
Prostate Cancer |
16.7% |
Febrile Neutropenia |
8.3% |
Hypocalcaemia |
8.3% |
Incorrect Route Of Drug Administration |
8.3% |
Memory Impairment |
8.3% |
Osteonecrosis Of Jaw |
8.3% |
Tooth Extraction |
8.3% |
Toothache |
8.3% |
Transient Ischaemic Attack |
8.3% |
Vitamin D Decreased |
8.3% |
Weight Decreased |
8.3% |
|